Answers are grounded in this paper and cite their sources.
Background: Postoperative pain following lung transplantation is substantial and contributes to opioid exposure, delirium risk, and prolonged recovery. We evaluated the impact of intraoperative intercostal nerve cryoablation on postoperative opioid use, delirium incidence, and early clinical outcomes. Methods: We conducted a single-center retrospective matched cohort study of adult lung transplant recipients. Patients who underwent intraoperative intercostal nerve cryoablation (intervention) were compared with a historical matched cohort of recipients who did not undergo cryoablation (control). The primary outcome was cumulative opioid use, measured in oral morphine milligram equivalents (MME), during the first 14 postoperative days. Secondary outcomes included delirium incidence, ventilator days, intensive care unit and hospital lengths of stay, and early postoperative complications. Results: The study included 19 patients in the cryoablation group and 38 matched controls. Cryoablation was associated with a reduction in cumulative opioid use through postoperative day 14 (428 MME vs. 603 MME, p=0.681). Rates of postoperative delirium were slightly lower in the intervention group (58% vs. 66%, p=0.571). Cryoablation was not associated with increased complications. There were trends toward shorter median ventilator duration and total hospital length of stay in the intervention group, although results were not statistically significant. Conclusion: Intraoperative intercostal nerve cryoablation is a feasible and safe adjunct in lung transplantation and is associated with reduced early postoperative opioid use. These findings support further prospective evaluation of cryoablation as an opioid-sparing strategy in lung transplant recipients.
No takes yet. Share an insight, caveat, or question.
Coppolino et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: